Keywords: Merck KGaA, Second-quarter 2010 financial results

Merck KGaA sees 2nd-qtr 2010 profits rocket around 70%, with revenues rising 15.6%

Article | 30 July 2010

German drugs and liquid crystals marker Merck KGaA posted a spectacular set of second-quarter 2010 results yesterday, beating consensus forecasts and causing a 5.9% rise to 68.08 euros in its share price, after reporting a 69% leap to 183.4 million euros ($235.1 million) in its net profit.

Profit after tax rose 70.1% to 326.2 million euros. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck KGaA

Go to company listing